Pfizer fined record £84.2m over NHS overcharging

Competition regulator says price of anti-epilepsy drug was increased by up to 2,600%The pharmaceutical company Pfizer has been fined a record £84.2m by the UK’s competition regulator after the price charged to the NHS for an anti-epilepsy drug was increased by up to 2,600%.The Competition and Markets Authority, issuing its biggest fine, said the “extraordinary price rises have cost the NHS and the taxpayer tens of millions of pounds”. Continue reading...